Intended for US audience only

Explore the Optune Lua System

Designed with you in mind

Optune Lua® is small, light, and weighs just 2.7 pounds.


Optune Lua is wearable and portable, so continuous treatment with TTFields can be received almost anywhere.

See how Optune Lua can fit into your daily life

Weighs less than most laptop computers.

For your convenience:
  • 5 different ways to carry your device so you can find what works for you
  • An easy-grip texture that allows for simple handling
  • Alerts to let you know when it's time to change the battery so you can keep receiving treatment
  • An auto-dimming feature that dims the device and charger in the dark
Optune Lua also includes:
  • Portable batteries
    • 4 batteries are provided with each kit; each battery will last at least 1 hour
  • Charger for portable batteries
    • Batteries will need to be recharged. The batteries can be charged and used many times over the course of treatment

Actor portrayal 

Receiving treatment wherever you go

You have the flexibility to decide which times of the day are best for you to use Optune Lua.

 

  • The device can be set on the nightstand next to you while you sleep
  • For sleeping, or other times when you plan to stay in the same place for a while, plug the device into a standard wall outlet
  • The device can be carried when you are using a battery

 

Remember:

 

  • You should turn on Optune Lua at least 75% of the time (18 hours per day)
  • Be sure to keep the arrays on your upper body, even during times when you turn Optune Lua off. Arrays should be replaced at least twice per week (every 4 days at most)
  • To get the best response from treatment, Optune Lua should be worn for about 18 hours a day. Wearing the arrays while you sleep can help you reach that goal. You can take breaks, if needed

 

Be sure to carry extra batteries when you are running errands or traveling.

MyLinkTM—an easier way to upload Optune Lua usage data

Optune Lua records the amount of time that therapy is delivered per day. To help you view that data, your MyLink device pairs with your Optune Lua device to securely transfer your usage data.

MyLink enables you to easily upload your electric field generator data from the comfort of your home. This means Novocure® can collect data more frequently to better support you.

Your device support specialist (DSS) can view your secure data remotely. Then your DSS can inform you about your device usage.

Next: Study Results with Optune Lua

Caution: Federal law restricts Optune Lua to sale by or on the order of a physician. Humanitarian Device. Authorized by Federal Law for use in the treatment of adult patients with unresectable, locally advanced or metastatic, malignant pleural mesothelioma concurrently with pemetrexed and platinum-based chemotherapy. The effectiveness of this device for this use has not been demonstrated.

 

What is Optune Lua® approved to treat?

Optune Lua is a wearable, portable, FDA-approved device indicated for the treatment of adult patients, with unresectable, locally advanced or metastatic, malignant pleural mesothelioma (MPM) to be used together with standard chemotherapy (pemetrexed and platinum-based chemotherapy).

 

What should not use Optune Lua?

Optune Lua is not for everyone. Talk to your doctor if you have: 

  • An implanted electronic medical device including a pacemaker, implantable automatic defibrillator, etc. Optune Lua has not been tested in people with implanted electronic devices, which may cause the devices not to work properly
  • A known sensitivity to conductive hydrogels (the gel on the arrays placed on the upper body like the ones used on EKGs). When Optune Lua comes into contact with the skin, it may cause more redness and itching or may rarely cause a life-threatening allergic reaction 

 

Do not use Optune Lua if you are pregnant or are planning to become pregnant. It is not known if Optune Lua is safe or effective during pregnancy.

 

What should I know before using Optune Lua?

Optune Lua should only be used after receiving training from qualified personnel, such as your doctor, a nurse, or other medical staff who have completed a training course given by Novocure®, the maker of Optune Lua.

  • Do not use any parts that did not come with Optune Lua sent to you by Novocure or given to you by your doctor 
  • Do not get the device or transducer arrays wet 
  • Please be aware that Optune Lua has a cord that may cause tripping when connected to an electric socket 
  • If you have an underlying serious skin condition on the upper body, discuss with your doctor whether this may prevent or temporarily interfere with the Optune Lua treatment

 

What are the possible side effects of Optune Lua?

Most common side effects of Optune Lua when used together with chemotherapy were low red blood cell count, constipation, nausea, tiredness, chest pain, fatigue, skin irritation from device use, itchy skin, and cough. 

Other potential adverse effects associated with the use of Optune Lua include: treatment related skin irritation, allergic reaction to the plaster or to the gel, electrode overheating leading to pain and/or local skin burns, infections at sites of electrode contact with the skin, local warmth and tingling sensation beneath the electrodes, muscle twitching, medical device site reaction and skin breakdown/skin ulcer. 

Talk to your doctor if you have any of these side effects or questions. 

 

Please click here to see the Optune Lua Instructions For Use (IFU) for complete information regarding the device’s indications, contraindications, warnings and precautions.

Novocure Websites

This website is intended for people seeking information on Optune Lua.

 

On this site, videos and images identified as Optune Lua users, care partners, or healthcare professionals depict actual patients, care partners, and healthcare professionals.

 

Patient images reflect the health status of the patients at the time each photo or video was taken.




©2024 Novocure GmbH. All Rights Reserved.

MyNovocure, Novocure, and Optune Lua are registered trademarks of Novocure GmbH.

US-OPL-00021 v1.0 August 2024